The near-infrared imaging market is projected to reach USD 2.08 billion by 2030 from USD 1.25 billion in 2025, at a CAGR of 10.6% from 2025 to 2030. The Near-Infrared (NIR) Imaging Market is experiencing significant acceleration as healthcare systems transition toward precision and image-guided care. NIR imaging, operating typically in the 650–900 nm range, enables superior tissue penetration and minimal background interference compared to visible light imaging—making it indispensable in intraoperative visualization, tumor detection, and preclinical pharmacokinetic studies. Market growth is driven by the expanding use of fluorescence-guided surgery, increasing deployment of hybrid NIR/visible cameras, and rapid integration of real-time analytics and AI-based quantification software. With wider acceptance in oncology, cardiovascular, and neurological procedures, NIR imaging has evolved from a research tool to a mainstream clinical adjunct supporting decision-making during complex surgeries.
Several macro- and micro-level trends are converging to transform the NIR imaging landscape. AI-enabled image quantification and machine learning-based segmentation are enhancing intraoperative accuracy and enabling automated identification of anatomical boundaries. Dual-channel NIR fluorescence systems capable of simultaneous visible and NIR visualization are improving surgical precision. Furthermore, advancements in targeted fluorophores—such as ICG derivatives, IRDye 800CW, and tumor-specific probes—are allowing molecular differentiation of malignant and healthy tissues. Miniaturized NIR sensors are enabling point-of-care (POC) and handheld devices for vascular imaging and reconstructive procedures. On the research side, multi-spectral NIR imaging is being combined with PET, MRI, and CT to create high-fidelity hybrid imaging data for drug discovery and translational medicine.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174869738
Driver: Technological advancements in near-infrared imaging modalities
The primary growth drivers include the rising incidence of cancer and cardiovascular diseases, the growing preference for image-guided surgeries, and the increasing demand for non-invasive diagnostic techniques. The technological evolution of fluorescence dyes & cameras and government-funded initiatives supporting preclinical and translational research are further propelling market expansion.
Opportunity: Growth opportunities in emerging countries
Emerging economies like India, China, Brazil, South Korea, Turkey, Russia, and South Africa present significant growth prospects for key players in the near-infrared imaging sector. While cost remains a concern in these developing nations, their vast populations—particularly in India and China—create a sustainable market for imaging devices. With over half of the world’s population living in these countries, they host a large patient demographic. As per GLOBOCAN 2018, Asia reported 8,750,932 cancer cases.
The device segment is expected to grow significantly from 2025 to 2030 in the near-infrared imaging market, by product.
By product, the device segment is expected to dominate the market during the forecast period. The device segment comprises fluorescence imaging systems and fluorescence & bioluminescence imaging systems. Key factors driving the growth of the device segment during this period include the advantages offered by this segment, including high-image resolution, high sensitivity, and real-time image guidance during surgeries.
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174869738
By application, the clinical imaging segment accounted for the largest share in 2024.
In 2024, the clinical imaging segment accounted for the largest market share. The Near IR imaging market is categorized into preclinical imaging, clinical imaging, and medical imaging. Key factors such as the advancements in fluorescence imaging for clinical applications and the increasing adoption of this imaging modality, owing to the advantages offered by this technique, are expected to drive the market growth of this segment in the coming years.
The Asia Pacific region is expected to register the highest growth during the forecast period.
The Asia Pacific region is expected to register the highest CAGR of ~12% in the near IR imaging market. This region includes countries such as China, India, South Korea, Taiwan, and Singapore. The growth of the near IR imaging market is driven by the large patient population, the rising geriatric population, rapid economic growth, and increasing disposable income in the region.
As of 2024, the leading companies in the near IR imaging market include Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Shimadzu Corporation (Japan), PerkinElmer, Inc. (US), LI-COR Biotech (US), Hamamatsu Photonics K.K. (Japan), Quest Medical Imaging B.V. (Netherlands), and Merck KGaA (Germany).
Enquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=174869738
